MenQuadfi

Country: Kesatuan Eropah

Bahasa: Finland

Sumber: EMA (European Medicines Agency)

Bahan aktif:

Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid

Boleh didapati daripada:

Sanofi Pasteur

Kod ATC:

J07AH08

INN (Nama Antarabangsa):

meningococcal group A, C, W-135 and Y conjugate vaccine

Kumpulan terapeutik:

rokotteet

Kawasan terapeutik:

Meningiitti, meningokokki

Tanda-tanda terapeutik:

MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.

Ringkasan produk:

Revision: 8

Status kebenaran:

valtuutettu

Tarikh kebenaran:

2020-11-18

Risalah maklumat

504 GATEWAY TIME-OUT

Ciri produk

504 GATEWAY TIME-OUT